A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sitagliptin, a DPP-4 inhibitor, has been evaluated in two paediatric type 2 diabetes studies and has not provided durable glycaemic control as an initial or add-on therapy.80,81”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 2×
“, Davies et al.(11)), the framework for the use of DPP-4 inhibitors in the management of hyperglycemia in adults with T2D depends on local practice guidelines.”
BackgroundNauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Charbonnel, B., Karasik, A., Liu, J., Wu, M., Meininger, G., & for the Sitagliptin Study 020 Group (2006) · Diabetes Care · doi:10.2337/dc06-0706 · Cited by 790
Raz, I., Hanefeld, M., Xu, L., Caria, C., Williams-Herman, D., Khatami, H., & Sitagliptin Study 023 Group (2006) · Diabetologia · doi:10.1007/s00125-006-0416-z · Cited by 614
Goldstein, B. J., Feinglos, M. N., Lunceford, J. K., Johnson, J., Williams-Herman, D. E., & for the Sitagliptin 036 Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0627 · Cited by 509
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
Vilsbøll, T., Rosenstock, J., Yki‐Järvinen, H., Cefalu, W. T., Chen, Y., Luo, E., Musser, B., Andryuk, P. J., Ling, Y., Kaufman, K. D., et al. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01173.x · Cited by 305
Self-citationTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
Kahn, S. E., Lachin, J. M., Zinman, B., Haffner, S. M., Aftring, R. P., Paul, G., Kravitz, B. G., Herman, W. H., Viberti, G., Holman, R. R., et al. (2011) · Diabetes · doi:10.2337/db10-1392 · Cited by 249
Research works printed but not linked: 42
- International Diabetes Federation, 2019, IDF Diabetes Atlas
- 10.1542/peds.2004-2536 · DOI · Paper page
- 10.1016/S0140-6736(17)31371-5 · DOI · Paper page
- 10.1056/NEJMoa1109333 · DOI · Paper page
- 10.1515/JPEM.2004.17.9.1185 · DOI
- 10.1080/17477160600586689 · DOI · Paper page
- 10.1007/s12519-019-00247-1 · DOI
- 10.2174/1573399814666180608074510 · DOI
- 10.1016/j.bcp.2011.11.028 · DOI · Paper page
- 10.1038/sj.clpt.6100167 · DOI · Paper page
- 10.1007/s13300-013-0024-0 · DOI · Paper page
- 10.2337/dc06-0703 · DOI · Paper page
- 10.1111/j.1463-1326.2009.01187.x · DOI · Paper page
- 10.1111/j.1742-1241.2006.01246.x · DOI · Paper page
- 10.1111/j.1463-1326.2006.00691.x · DOI · Paper page
- 10.1111/j.1463-1326.2006.00704.x · DOI · Paper page
- 10.1185/030079908X260925 · DOI · Paper page
- 10.1111/j.1742-1241.2010.02353.x · DOI · Paper page
- 10.1185/03007990802705679 · DOI · Paper page
- 10.1111/j.1463-1326.2010.01204.x · DOI · Paper page
- 10.1111/j.1463-1326.2011.01492.x · DOI
- 10.1007/s13300-015-0105-3 · DOI
- 10.1111/dom.13574 · DOI
- 10.1111/pedi.12790 · DOI
- 10.1038/ijo.2009.195 · DOI
- Liang KY, 2000, Longitudinal data analysis of continuous and discrete responses for pre‐post designs, Indian J Stat, 62, 134
- 10.1002/sim.4780040211 · DOI · Paper page
- 10.1056/NEJMoa066224 · DOI · Paper page
- The RISE Consortium, 2019, Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on beta‐cell function: comparison of responses in youth and adults, Diabetes, 68, 1670
- 10.1111/pedi.12953 · DOI
- 10.1111/j.1464-5491.2010.02941.x · DOI · Paper page
- 10.1111/j.1464-5491.2010.03155.x · doi:10.1111/j.1464-5491.2010.03155.x
- 10.1185/030079907X188152 · DOI · Paper page
- 10.1056/NEJMoa1903822 · DOI · Paper page
- 10.1007/s40265-013-0169-1 · DOI
- 10.1089/dia.2013.0366 · DOI · Paper page
- 10.7326/0003-4819-153-6-201009210-00008 · DOI · Paper page
- 10.2337/dc13-1838 · DOI · Paper page
- 10.1007/s11892-018-0997-1 · DOI
- 10.15585/mmwr.mm6906a3 · DOI · Paper page
- 10.1111/pedi.12763 · DOI
- 10.1111/pedi.12281 · DOI · Paper page
Cited by
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
Jalaludin, M. Y., Deeb, A., Zeitler, P., Garcia, R., Newfield, R. S., Samoilova, Y., Rosario, C. A., Shehadeh, N., Saha, C. K., Zhang, Y., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13282 · Cited by 31
Self-citation
Metadata
- Authors
- Shankar, R. R., Zeitler, P., Deeb, A., Jalaludin, M. Y., Garcia, R., Newfield, R. S., Samoilova, Y., Rosario, C. A., Shehadeh, N., Saha, C. K., Zhang, Y., Zilli, M., Scherer, L. W., Lam, R. L. H., Golm, G. T., Engel, S. S., & Kaufman, K. D.
- Affiliations
- Merck Research Laboratories Merck & Co., Inc. Kenilworth New Jersey USA
- Department of Endocrinology, Children's Hospital Colorado Clinical University of Colorado Anschutz Medical Campus Aurora Colorado USA
- Department of Pediatric Endocrinology Sheikh Shakhbout Medical City Abu Dhabi United Arab Emirates
- Department of Paediatrics, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia
- Department of Internal Medicine and Clinical Endocrinology Centro de Estudios Clínicos y Especialidades Medicas (CECEM) Nuevo Leon Mexico
- Department of Pediatric Endocrinology, Rady Children's Hospital University of California San Diego San Diego California USA
- Department of Pediatric Endocrinology and Diabetology Siberian State Medical University Tomsk Russia
- Department of Pediatric Endocrinology Hospital General Plaza de la Salud Santo Domingo Dominican Republic
- Department of Pediatrics A and the Pediatric Diabetes Unit, Institute of Diabetes, Endocrinology, and Metabolism Rambam Medical Center Haifa Israel
- Department of Biostatistics Indiana University School of Medicine Indianapolis Indiana USA
- ORCID
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2021-12-22
- Volume
- 23
- Issue
- 2
- Pages
- 173-182
- ISSN
- 1399-543X
- 1399-5448
- Cited by
- 31
- References
- 9
- Language
- en
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Merck KGaA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. https://app.cochat.ai/papers/10.1111/pedi.13279
- The paper
- Shankar, R. R., Zeitler, P., Deeb, A., Jalaludin, M. Y., Garcia, R., Newfield, R. S., Samoilova, Y., Rosario, C. A., Shehadeh, N., Saha, C. K., Zhang, Y., Zilli, M., Scherer, L. W., Lam, R. L. H., Golm, G. T., Engel, S. S., & Kaufman, K. D. (2022). A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Pediatric Diabetes. https://doi.org/10.1111/pedi.13279
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.